Immunological monitoring and clinical trials of biological response modifiers

Cancer Chemother Biol Response Modif. 1994:15:226-86.

Authors

W C Kopp¹, J T Holmlund, W J Urba

Affiliation

¹ Program Resources Inc., National Cancer Institute, Frederick Cancer Research and Development Center, MD, USA.

PMID: 7540029

No abstract available

Publication types

Review

MeSH terms

Animals
Clinical Trials as Topic
Humans
Immunologic Factors / therapeutic use*
Interferons / therapeutic use
Interleukin-2 / therapeutic use
Interleukin-2 / toxicity
Interleukin-3 / therapeutic use
Macrophage Colony-Stimulating Factor / therapeutic use
Melatonin / therapeutic use
Monitoring, Immunologic
Neoplasms / immunology
Neoplasms / therapy*
Tumor Necrosis Factor-alpha / therapeutic use

Substances

Immunologic Factors
Interleukin-2
Interleukin-3
Tumor Necrosis Factor-alpha
Macrophage Colony-Stimulating Factor
Interferons
Melatonin